These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


177 related items for PubMed ID: 11449608

  • 1. [Preventive monotherapy with montelukast versus DNCG in children with mild asthma. Results of and exploratory pilot study].
    Liebke C, Sommerfeld C, Wahn U, Niggemann B.
    Pneumologie; 2001 May; 55(5):231-7. PubMed ID: 11449608
    [Abstract] [Full Text] [Related]

  • 2. Oral montelukast versus inhaled beclomethasone in 6- to 11-year-old children with asthma: results of an open-label extension study evaluating long-term safety, satisfaction, and adherence with therapy.
    Maspero JF, Dueñas-Meza E, Volovitz B, Pinacho Daza C, Kosa L, Vrijens F, Leff JA.
    Curr Med Res Opin; 2001 May; 17(2):96-104. PubMed ID: 11759189
    [Abstract] [Full Text] [Related]

  • 3. Comparative study of budesonide inhalation suspension and montelukast in young children with mild persistent asthma.
    Szefler SJ, Baker JW, Uryniak T, Goldman M, Silkoff PE.
    J Allergy Clin Immunol; 2007 Nov; 120(5):1043-50. PubMed ID: 17983871
    [Abstract] [Full Text] [Related]

  • 4. The effect of treatment with montelukast on levels of serum interleukin-10, eosinophil cationic protein, blood eosinophil counts, and clinical parameters in children with asthma.
    Yüksel B, Aydemir C, Ustündag G, Eldeş N, Kutsal E, Can M, Demirtaş S, Tomaç N.
    Turk J Pediatr; 2009 Nov; 51(5):460-5. PubMed ID: 20112601
    [Abstract] [Full Text] [Related]

  • 5. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L, Bisgaard H, Bousquet J, Fabbri LM, Greening A, Haahtela T, Holgate ST, Picado C, Leff JA.
    Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S.
    Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
    [Abstract] [Full Text] [Related]

  • 7. Review of recent results of montelukast use as a monotherapy in children with mild asthma.
    Wahn U, Dass SB.
    Clin Ther; 2008 Aug; 30 Spec No():1026-35. PubMed ID: 18640477
    [Abstract] [Full Text] [Related]

  • 8. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma.
    Szefler SJ, Phillips BR, Martinez FD, Chinchilli VM, Lemanske RF, Strunk RC, Zeiger RS, Larsen G, Spahn JD, Bacharier LB, Bloomberg GR, Guilbert TW, Heldt G, Morgan WJ, Moss MH, Sorkness CA, Taussig LM.
    J Allergy Clin Immunol; 2005 Feb; 115(2):233-42. PubMed ID: 15696076
    [Abstract] [Full Text] [Related]

  • 9. Sodium cromoglycate alone and in combination with montelukast on the airway response to mannitol in asthmatic subjects.
    Anderson SD, Brannan JD, Perry CP, Caillaud C, Seale JP.
    J Asthma; 2010 May; 47(4):429-33. PubMed ID: 20528598
    [Abstract] [Full Text] [Related]

  • 10. Montelukast improves asthma control in asthmatic children maintained on inhaled corticosteroids.
    Phipatanakul W, Greene C, Downes SJ, Cronin B, Eller TJ, Schneider LC, Irani AM.
    Ann Allergy Asthma Immunol; 2003 Jul; 91(1):49-54. PubMed ID: 12877449
    [Abstract] [Full Text] [Related]

  • 11. A randomized study comparing the effect of loratadine added to montelukast with montelukast, loratadine, and beclomethasone monotherapies in patients with chronic asthma.
    Lu S, Liu N, Dass SB, Reiss TF.
    J Asthma; 2009 Jun; 46(5):465-9. PubMed ID: 19544166
    [Abstract] [Full Text] [Related]

  • 12. Effect of montelukast on peripheral airflow obstruction in children with asthma.
    Spahn JD, Covar RA, Jain N, Gleason M, Shimamoto R, Szefler SJ, Gelfand EW.
    Ann Allergy Asthma Immunol; 2006 Apr; 96(4):541-9. PubMed ID: 16680924
    [Abstract] [Full Text] [Related]

  • 13. Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot study.
    Dupont L, Potvin E, Korn D, Lachman A, Dramaix M, Gusman J, Peché R, Singulair as Complementary Therapy to Fixed Association in Real life Study Group.
    Curr Med Res Opin; 2005 Jun; 21(6):863-9. PubMed ID: 15969886
    [Abstract] [Full Text] [Related]

  • 14. Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial.
    Sorkness CA, Lemanske RF, Mauger DT, Boehmer SJ, Chinchilli VM, Martinez FD, Strunk RC, Szefler SJ, Zeiger RS, Bacharier LB, Bloomberg GR, Covar RA, Guilbert TW, Heldt G, Larsen G, Mellon MH, Morgan WJ, Moss MH, Spahn JD, Taussig LM, Childhood Asthma Research and Education Network of the National Heart, Lung, and Blood Institute.
    J Allergy Clin Immunol; 2007 Jan; 119(1):64-72. PubMed ID: 17140647
    [Abstract] [Full Text] [Related]

  • 15. A clinical trial of the efficacy and safety of montelukast as monotherapy in patients with chronic stable bronchial asthma.
    Athavale A, Souza GA, Avasthi R, Singh NP, Kale M, Taneja A, Sireesha K.
    J Indian Med Assoc; 2004 Feb; 102(2):109-11. PubMed ID: 15200214
    [Abstract] [Full Text] [Related]

  • 16. Short-term and long-term asthma control in patients with mild persistent asthma receiving montelukast or fluticasone: a randomized controlled trial.
    Zeiger RS, Bird SR, Kaplan MS, Schatz M, Pearlman DS, Orav EJ, Hustad CM, Edelman JM.
    Am J Med; 2005 Jun; 118(6):649-57. PubMed ID: 15922697
    [Abstract] [Full Text] [Related]

  • 17. The effect of montelukast versus usual care on health care resource utilization in children aged 2 to 5 years with asthma.
    Davies GM, Dasbach EJ, Santanello NC, Knorr BA, Bratton DL.
    Clin Ther; 2004 Nov; 26(11):1895-904. PubMed ID: 15639701
    [Abstract] [Full Text] [Related]

  • 18. Montelukast in asthmatic patients 6 years-14 years old with an FEV1 > 75%.
    Becker A, Swern A, Tozzi CA, Yu Q, Reiss T, Knorr B.
    Curr Med Res Opin; 2004 Oct; 20(10):1651-9. PubMed ID: 15462699
    [Abstract] [Full Text] [Related]

  • 19. Analysis of montelukast in mild persistent asthmatic patients with near-normal lung function.
    Barnes N, Wei LX, Reiss TF, Leff JA, Shingo S, Yu C, Edelman JM.
    Respir Med; 2001 May; 95(5):379-86. PubMed ID: 11392579
    [Abstract] [Full Text] [Related]

  • 20. Comparative effect of triamcinolone, nedocromil and montelukast on asthma control in children: A randomized pragmatic study.
    Stelmach I, Majak P, Jerzynska J, Stelmach W, Kuna P.
    Pediatr Allergy Immunol; 2004 Aug; 15(4):359-64. PubMed ID: 15305946
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.